KRT18 and metabolic dysfunction-associated steatohepatitis: Multiple circulating biomarkers have also been used for diagnosis, such as caspase-generated cytokeratin-18 (CK-18) fragment concentration, which is a biomarker of hepatocyte apoptosis in the context of NASH [54,59].